Preeclampsia Diagnostics Market Players:
- ACON Laboratories Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bio Rad Laboratories Inc.
- BioCheck Inc.
- bioMerieux SA
- Cardinal Health Inc.
- Diabetomics Inc.
- F. Hoffmann La Roche Ltd.
- Thermo Fisher Inc.
- Biora Therapeutics Inc
- Sysmex Corporation
- Hitachi Ltd.
- Fujirebio Diagnostics
- Siemens Healthineers AG
- Fujifilm Corporation
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of preeclampsia diagnostics is evaluated at USD 2.48 Billion.
The global preeclampsia diagnostics market size was worth around USD 2.27 Billion in 2025 and is set to register a CAGR of more than 10.2%, exceeding USD 6 Billion revenue by 2035.
The North America preeclampsia diagnostics market will secure around 35% share by 2035, fueled by a focus on drug delivery, vaccine development, advancements in biotechnology, and maternal health awareness.
Key players in the market include of Cardinal Health Inc., Diabetomics Inc., F. Hoffmann La Roche Ltd., Thermo Fisher Inc., Biora Therapeutics Inc.
